Entera Bio Ltd.
ENTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2020 | Q2 2019 |
|---|---|---|
| Revenue | $52.00K | $74.00K |
| Net Income | -$3.19M | -$1.37M |
| EPS Diluted | $0.17 | $0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Entera Bio Ltd. · CIK 1638097 · Engraved from SEC EDGAR